Initially there was no specific way to reverse like you know okay I mean the anticoagulant effect of dabigatran in the event of a well okay uh okay major bleeding event, unlike for warfarin, but a dabigatran so I mean so um antidote (idarucizumab) was approved by the FDA in 2015.